A comparative study between two technique using levobupivacine for pain management after laparoscopic gall bladder removal surgery.
Not Applicable
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2023/10/058669
- Lead Sponsor
- Dr Ratnesh Kumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) American Society of Anaesthesiologists (ASA) Physical status I and II
2) Age from 18-60 years
3) Scheduled to undergo elective Laparoscopic Cholecystectomy under General Anaesthesia using four port.
Exclusion Criteria
1) Patient refusal
2) ASA III and IV patients
3) Patient with history of drug allergy to Levobupivacaine
4) Patients who are unable to communicate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To measure the duration of analgesia which is the time to the first request for rescue analgesic or Visual Analogue Scale (VAS) more than 5Timepoint: For next 24 hours, after the transverse abdominis plane block or local infiltration.
- Secondary Outcome Measures
Name Time Method 1) To study the quality of analgesia by visual analogue scale <br/ ><br>2) To measure the hemodynamic parameters ( Heart rate, Blood pressure, Mean Arterial Pressure, SPO2) <br/ ><br>3) To find the number of times rescue analgesia required <br/ ><br>4) To find associated side effects of procedure (Nausea, Vomiting, Shivering, Hypotension, Bradycardia, Hypersensitive Reaction).Timepoint: For next 24 hours, after the transverse abdominis plane block or local infiltration.